𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human ovarian carcinoma lysis by cytotoxic t cells targeted by bispecific monoclonal antibodies: Analysis of the antibody components

✍ Scribed by D. Mezzanzanica; S. Canevari; S. Ménard; S. M. Pupa; E. Tagliabue; A. Lanzavecchia; M. I. Colnaghi

Book ID
118283970
Publisher
John Wiley and Sons
Year
1988
Tongue
French
Weight
866 KB
Volume
41
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of bispecific monoclonal anti
Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes
✍ Cor H. J. Lamers; Jan W. Gratama; Sven O. Warnaar; Gerrit Stoter; Reinder L. H. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 743 KB

T lymphocytes of 8 patients with ovarian cancer were targeted to the tumor cells using F(ab')2 fragments of a bispecific monoclonal antibody (bsAb), specific for CD3 (a component of the T lymphocyte receptor for antigen) and for the folate receptor MOv I 8 (overexpressed by ovarian carcinoma cells)

Anti-ovarian carcinoma anti-T3 heterocon
Anti-ovarian carcinoma anti-T3 heteroconjugates or hybrid antibodies induce tumor cell lysis by cytotoxic T-cells
✍ Sitvana Canevari; Sylvie Ménard; Delia Mezzanzanica; Silvia Mjotti; Screnella M. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 320 KB

In the perspective of therapeutic in vivo targeting for T-cell attack, the monoclonal antibody (MAb) MOvI8, selected for i t s restricted reactivity with human ovarian carcinoma, and an anti-T3 MAb were used t o produce heteroconjugate or hybrid antibodies derived by fusion of relevant hybridomas. S